These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2299628)

  • 21. Effects of dantrolene sodium in rodent models of cardiac arrhythmia.
    Brooks RR; Carpenter JF; Jones SM; Gregory CM
    Eur J Pharmacol; 1989 May; 164(3):521-30. PubMed ID: 2767123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of AHR-12234 on cardiac transmembrane action potentials, in situ cardiac electrophysiology and experimental models for arrhythmias.
    Wu KM; Proakis AG; Hunter TL; Shanklin JR
    Arch Int Pharmacodyn Ther; 1989; 301():131-50. PubMed ID: 2624512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
    Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
    Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness?
    Hashimoto K; Haruno A; Matsuzaki T; Sugiyama A; Akiyama K
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():805-17. PubMed ID: 1657110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and pharmacological studies of N-substituted 6-[(2-aminoethyl)amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinediones, novel class III antiarrhythmic agents.
    Katakami T; Yokoyama T; Miyamoto M; Mori H; Kawauchi N; Nobori T; San-nohe K; Kaiho T; Kamiya J
    J Med Chem; 1992 Sep; 35(18):3325-30. PubMed ID: 1527781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of the class III antiarrhythmic agent sematilide in patients with arrhythmias.
    Wong W; Pavlou HN; Birgersdotter UM; Hilleman DE; Mohiuddin SM; Roden DM
    Am J Cardiol; 1992 Jan; 69(3):206-12. PubMed ID: 1731461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-[(omega-amino-1-hydroxyalkyl)phenyl]methanesulfonamide derivatives with class III antiarrhythmic activity.
    Hester JB; Gibson JK; Cimini MG; Emmert DE; Locker PK; Perricone SC; Skaletzky LL; Sykes JK; West BE
    J Med Chem; 1991 Jan; 34(1):308-15. PubMed ID: 1992131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class III drug, sematilide, using a canine chronic atrioventricular block model.
    Yoshida H; Sugiyama A; Satoh Y; Ishida Y; Yoneyama M; Kugiyama K; Hashimoto K
    Circ J; 2002 Aug; 66(8):758-62. PubMed ID: 12197602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiarrhythmic activity of p-hydroxy-N-(2-diethylaminoethyl) benzamide (the p-hydroxy isostere of procainamide) in dogs and mice.
    Drayer DE; Slaven BH; Reidenberg MM; Bagwell EE; Cordova M
    J Med Chem; 1977 Feb; 20(2):270-4. PubMed ID: 836498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and antiarrhythmic activity of 2,5-disubstituted 2,3-dihydro-1,2,5-benzothiadiazepin-4(5H)-one 1,1-dioxides.
    Ogawa K; Matsushita Y
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2442-7. PubMed ID: 1446366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Actions of a newly synthesized compound (711389-S) on various types of experimentally induced arrhythmias in mammalian species in situ.
    Kadowaki Y; Ohta T; Hotokebuchi N; Kimoto S; Haruna M; Nakao T; Ueda M; Nishi K
    Jpn J Pharmacol; 1988 Apr; 46(4):359-72. PubMed ID: 3404766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compounds.
    Lis R; Morgan TK; DeVita RJ; Davey DD; Lumma WC; Wohl RA; Diamond J; Wong SS; Sullivan ME
    J Med Chem; 1987 Apr; 30(4):696-704. PubMed ID: 3560162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of sematilide, a novel class III antiarrhythmic agent, on membrane currents in rabbit atrial myocytes.
    Ishii Y; Muraki K; Kurihara A; Imaizumi Y; Watanabe M
    Eur J Pharmacol; 1997 Jul; 331(2-3):295-302. PubMed ID: 9274992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].
    Fukuda H; Goto M; Kondo M; Uchigasaki T; Sekino Y
    Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):115-26. PubMed ID: 6852683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological characterization of BRL-32872 in canine Purkinje fiber and ventricular muscle. Effect on early after-depolarizations and repolarization dispersion.
    Faivre JF; Forest MC; Gout B; Bril A
    Eur J Pharmacol; 1999 Oct; 383(2):215-22. PubMed ID: 10585537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac electrophysiologic effects of R 54718.
    Johnson N; Spinelli W; Rosen MR
    Eur J Pharmacol; 1987 Mar; 135(1):41-51. PubMed ID: 3569425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new class-III antiarrhythmic preparation among the dicyclohexylamides of aminocarboxylic acids].
    Kaverina NV; Lyskovtsev VV; Sokolov SF; Poppe H; Marx D; Kishchuk EP; Turilova AI; Likhosherstov AM; Tsorin IB; Chichkanov GG
    Vestn Ross Akad Med Nauk; 1998; (11):42-6. PubMed ID: 9889705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
    Bergey JL; Sulkowski T; Much DR; Wendt RL
    Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo Experiments.
    Kohajda Z; Farkas-Morvay N; Jost N; Nagy N; Geramipour A; Horváth A; Varga RS; Hornyik T; Corici C; Acsai K; Horváth B; Prorok J; Ördög B; Déri S; Tóth D; Levijoki J; Pollesello P; Koskelainen T; Otsomaa L; Tóth A; Baczkó I; Leprán I; Nánási PP; Papp JG; Varró A; Virág L
    PLoS One; 2016; 11(11):e0166041. PubMed ID: 27832106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic drugs: electrophysiological basis of their clinical usage.
    Weng JT; Smith DE; Moulder PV
    Ann Thorac Surg; 1986 Jan; 41(1):106-12. PubMed ID: 2417568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.